CAM
ZBH icon

Cresset Asset Management’s Zimmer Biomet ZBH Stock Holding History

Cresset Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79M Buy
41,801
+1,541
+4% +$141K 0.02% 423
2025
Q4 		$3.63M Buy
40,260
+17
+0% +$1.61K 0.02% 430
2025
Q3 		$3.97M Buy
40,243
+10
+0% +$991 0.02% 391
2025
Q2 		$3.68M Sell
40,233
-2,986
-7% -$289K 0.02% 380
2025
Q1 		$4.9M Buy
43,219
+6,011
+16% +$643K 0.02% 351
2024
Q4 		$3.94M Sell
37,208
-8,477
-19% -$910K 0.02% 397
2024
Q3 		$4.94M Sell
45,685
-218
-0.5% -$23.8K 0.02% 457
2024
Q2 		$4.99M Sell
45,903
-1,337
-3% -$158K 0.02% 427
2024
Q1 		$6.25M Buy
47,240
+5,700
+14% +$712K 0.03% 340
2023
Q4 		$5.07M Sell
41,540
-6,029
-13% -$673K 0.03% 336
2023
Q3 		$5.35M Buy
47,569
+2,714
+6% +$345K 0.02% 319
2023
Q2 		$6.54M Buy
44,855
+10,727
+31% +$1.46M 0.01% 352
2023
Q1 		$4.41M Buy
34,128
+32,414
+1,891% +$4.07M 0.09% 141
2022
Q4 		$211K Sell
1,714
-288
-14% -$33.4K ﹤0.01% 622
2022
Q3 		$210K Buy
2,002
+8
+0.4% +$878 ﹤0.01% 782
2022
Q2 		$209K Sell
1,994
-1,184
-37% -$140K ﹤0.01% 828
2022
Q1 		$408K Sell
3,178
-27
-0.8% -$3.25K ﹤0.01% 671
2021
Q4 		$396K Sell
3,205
-1,292
-29% -$169K ﹤0.01% 777
2021
Q3 		$640K Buy
4,497
+475
+12% +$69.9K 0.01% 534
2021
Q2 		$629K Buy
4,022
+253
+7% +$41K 0.01% 489
2021
Q1 		$586K Buy
3,769
+496
+15% +$76.8K 0.01% 435
2020
Q4 		$491K Sell
3,273
-351
-10% -$49.6K 0.01% 400
2020
Q3 		$479K Buy
3,624
+229
+7% +$29.9K 0.01% 382
2020
Q2 		$394K Buy
3,395
+73
+2% +$8.41K 0.01% 383
2020
Q1 		$327K Buy
3,322
+1,009
+44% +$132K 0.01% 366
2019
Q4 		$336K Buy
2,313
+547
+31% +$75.5K 0.01% 392
2019
Q3 		$235K Buy
1,766
+18
+1% +$2.33K 0.01% 453
2019
Q2 		$200K Buy
1,748
+1,371
+364% +$161K 0.01% 450
2019
Q1 		$47K Buy
377
+166
+79% +$18.9K ﹤0.01% 809
2018
Q4 		$21K Buy
+211
New +$23.7K ﹤0.01% 704

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cresset Asset Management's ZBH Position: Q1 2026 in Review

Cresset Asset Management increased its Zimmer Biomet (ZBH) stake by 3.8% in Q1 2026, buying an estimated $141K and bringing the position to 41,801 shares worth $3.79M. The position accounts for 0.02% of the portfolio, ranked #423.

Cresset Asset Management first reported a position in ZBH in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.54M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Cresset Asset Management held 41,801 shares of Zimmer Biomet worth $3.79M as of Q1 2026.
  • Cresset Asset Management bought 1,541 Zimmer Biomet shares in Q1 2026, an estimated $141K.
  • Zimmer Biomet made up 0.02% of Cresset Asset Management's portfolio in Q1 2026, its #423 holding.
  • Cresset Asset Management first reported a position in Zimmer Biomet in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Zimmer Biomet position peaked at $6.54M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.